Altogether, our results from this study on N-cadherin combined with previous reports on E-cadherin provide evidence that EMT and cadherin switching can occur in diabetic nephropathy and may be mediating the pathophysiological changes associated with it. This evidence concerns the gene CDH2 and diabetic kidney disease.